Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission-Reference-Cited by-同舟云学术

Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission

Published:2016-01-04 Issue:7 Volume:57 Page:1560-1566
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mannis Gabriel N.,Martin Thomas G.,Damon Lloyd E.,Logan Aaron C.,Olin Rebecca L.,Flanders Michael D.,Ai Weiyun Z.,Gaensler Karin M. L.,Kaplan Lawrence D.,Sayre Peter H.,Smith Catherine C.,Wolf Jeffrey L.,Andreadis Charalambos

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1088646

Reference32 articles.

1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

2. Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

3. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

4. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

5. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow transplant for the patient with primary immune deficiency disorder;Allergic and Immunologic Diseases;2022

2. Stem Cell Transplantation in Acute Myeloid Laeukemia;Acute Leukemias;2021-03-24

3. Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy;Hematology Reports;2020-12-02

4. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT);Biology of Blood and Marrow Transplantation;2020-04

5. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non–High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts;Clinical Lymphoma Myeloma and Leukemia;2019-08